Atrium Health Stanly/LCI-Albemarle is a clinical research site located in Albemarle, North Carolina, United States 28002.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Atrium Health Stanly/LCI-Albemarle has participated in 34 clinical trials with 29 currently active.
Therapeutic areas: Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma.
Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), NRG Oncology.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Atrium Health Stanly/LCI-Albemarle has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Atrium Health Stanly/LCI-Albemarle has 34 clinical trials on record, with 29 currently active. Their work covers Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma.
Yes — Atrium Health Stanly/LCI-Albemarle holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.